title: Repurposed biological scaffolds: kidney to pancreas.
abstract: Advances in organ regeneration have been facilitated by gentle decellularization protocols that maintain distinct tissue compartments, and thereby allow seeding of blood vessels with endothelial lineages separate from populations of the parenchyma with tissue-specific cells. We hypothesized that a reconstituted vasculature could serve as a novel platform for perfusing cells derived from a different organ: thus discordance of origin between the vascular and functional cells, leading to a hybrid repurposed organ. The need for a highly vascular bed is highlighted by tissue engineering approaches that involve transplantation of just cells, as attempted for insulin production to treat human diabetes. Those pancreatic islet cells present unique challenges since large numbers are needed to allow the cell-to-cell signaling required for viability and proper function; however, increasing their number is limited by inadequate perfusion and hypoxia. As proof of principle of the repurposed organ methodology we harnessed the vasculature of a kidney scaffold while seeding the collecting system with insulin-producing cells. Pig kidneys were decellularized by sequential detergent, enzymatic and rinsing steps. Maintenance of distinct vascular and collecting system compartments was demonstrated by both fluorescent 10 micron polystyrene microspheres and cell distributions in tissue sections. Sterilized acellular scaffolds underwent seeding separately via the artery (fibroblasts or endothelioma cells) and retrograde (murine βTC-tet cells) up the ureter. After three-day bioreactor incubation, histology confirmed separation of cells in the vasculature from those in the collecting system. βTC-tet clusters survived in tubules, glomerular Bowman's space, demonstrated insulin immunolabeling, and thereby supported the feasibility of kidney-to-pancreas repurposing.
authors.affiliation: a University of Central Florida ; Orlando , FL USA.
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: Willenberg
authors.forename: Jose
authors.initials: J
authors.lastname: Oca-Cossio
authors.forename: Yunqing
authors.initials: Y
authors.lastname: Cai
authors.forename: Alicia R
authors.initials: AR
authors.lastname: Brown
authors.forename: William L
authors.initials: WL
authors.lastname: Clapp
authors.forename: Dale R
authors.initials: DR
authors.lastname: Abrahamson
authors.forename: Naohiro
authors.initials: N
authors.lastname: Terada
authors.forename: Gary W
authors.initials: GW
authors.lastname: Ellison
authors.forename: Clayton E
authors.initials: CE
authors.lastname: Mathews
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Batich
authors.forename: Edward A
authors.initials: EA
authors.lastname: Ross
mesh_terms: D000818:Animals; D001705:Bioprosthesis; D004867:Equipment Design; D019544:Equipment Failure Analysis; D017743:Equipment Reuse; D007668:Kidney / Q000166:cytology / Q000254:growth & development*; D007688:Kidneys, Artificial; D051379:Mice; D019397:Pancreas, Artificial; D013552:Swine; D023822:Tissue Engineering / Q000295:instrumentation*; D054457:Tissue Scaffolds
keywords: decellularization; diabetes; organogenesis; stem cells; tissue engineering